NewsBlaze search box Daily News header

Hormones: Still Pushed by Pharma; Still Dangerous

By

The medical press trumpeted again this month the shopworn pharma factoid that menopausal hormones may be good for you, not bad. This is at least the eighth time researchers have tried to resuscitate the therapy and its franchise profits since a government study linked it to cancer and heart disease in 2002.

The report stemmed from a poster Dr. Joseph Ragaz, clinical professor at the University of British Columbia, presented at the San Antonio Breast Cancer Symposium this month.

The evidence that estrogen can protect against breast cancer has "been largely ignored" news reports quote Dr. Joseph Ragaz saying.

sleepz

Estrogen was once thought "the culprit in the elevated breast cancer risk seen among women" in the government-funded Women's Health Initiative, says a Medpage article.

That study, funded by the National Heart, Lung and Blood Institute, was terminated in 2002 because the risks to women outweighed the benefits. Progestin with estrogen were linked to a 26 percent increase in breast cancer, 41 percent increase in strokes, 29 percent increase in heart attacks, 22 percent increase in cardiovascular disease and double the rate of blood clots.

Hormone therapy is also linked to lung, ovarian, breast and gall bladder cancer, melanoma and dementia in medical studies and journal articles. Over 5,000 women have brought suit over breast cancers they developed on the drugs.

But what Medpage does not mention is that progestin was added to estrogen because women taking estrogen alone developed endometrial cancer!

So many women developed endometrial cancer, the cancer rate actually dropped when they quit taking estrogen by itself, usually as the drug Premarin, in the 1980s.

Just like the breast cancer rate fell when women quit taking estrogen and progestin, usually as Prempro, in 2002.

Why are reports that a drug that causes endometrial cancer but may reduce breast cancer good news? Is the idea to switch cancers?

And why are Pfizer-linked researchers at major universities trying to bring back the lucrative franchise by testing cognitive and cardiovascular "benefits" in defiance of hormones' known heart and dementia side effects?

Does anyone need a second opinion?

Martha Rosenberg is a columnist and cartoonist, who writes about public health

  Please leave a comment here     If it does not display within 10 seconds, please refresh the page

Related Health News News

Food Hero Mimi Kozma prepares dishes suitable for children with disabilities, launched an IndieGoGo campaign to raise funds for her show's second season.
30 million people in America suffer from diabetes. Here are two ways to help ensure you don't develop this potentially devastating health condition.
A painful lesson of the outbreak is that Ebola thrives in places with fragile and under-resourced public health systems, and on the poorest in these places.
Researchers at the Salk Institute found a diet high in fat may provide benefits for human patients suffering with mitochondrial disease.
There are many reasons people start taking drugs, but it is hard to stop, even though people think addiction will not get them. Do not connect with addicts.
The application deadline for AAAS and & SciLifeLab Prize For Young Scientists is in 28 days. This prize is for graduate work by recent PhD's.

 

NewsBlaze Writers Of The Month


Popular Stories This Month

newsletter logo

NewsBlaze
Copyright © 2004-2014 NewsBlaze Pty. Ltd.
Use of this website is subject to our Terms of Service and Privacy Policy  | DMCA Notice               Press Room   |    Visit NewsBlaze Mobile Site